Evidence map›Paper›PMID 36634015›Full record

ArticleExperimental and clinical psychopharmacology2023

Effects of oral Δ9-tetrahydrocannabinol and cannabidiol combinations on a sustained attention task in rats.

Catherine F Moore, Catherine M Davis, Cristina Sempio, Jost Klawitter, Uwe Christians, Elise M Weerts

Open access · greenAbstract read
In one paragraph

Article in Experimental and clinical psychopharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Chronic ΔBritish journal of pharmacology · 2025
    Article
  6. Phytocannabinoids restore seizure-induced alterations in emotional behaviour in male rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Catherine F MooreDivision of Behavioral Biology, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine.ORCID 0000-0003-0198-4788
Catherine M DavisDepartment of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences.
Cristina SempioiC42 Clinical Research and Development, Department of Anesthesiology, University of Colorado, Anschutz Medical Campus.
Jost KlawitteriC42 Clinical Research and Development, Department of Anesthesiology, University of Colorado, Anschutz Medical Campus.ORCID 0000-0002-6413-4820
Uwe ChristiansiC42 Clinical Research and Development, Department of Anesthesiology, University of Colorado, Anschutz Medical Campus.
Elise M WeertsDivision of Behavioral Biology, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine.ORCID 0000-0002-8234-0919
University of Colorado Anschutz Medical Campus · USJohns Hopkins University · USUniformed Services University of the Health Sciences · US

Funding

Development of a preclinical cannabinoid vaping modelR21DA046154 · NIDA · JOHNS HOPKINS UNIVERSITY · PI WEERTS, ELISE M · 2018 to 2019
$450k
Johns Hopkins UniversityNIDA NIH HHS R21 DA046154
6 · The paper itself

Abstract

A well-documented side effect of cannabis and Δ9-tetrahydrocannabinol (THC) acute administration is deficits in cognition and attention. Cannabidiol (CBD), a nonintoxicating constituent of cannabis, may modulate THC's impairing effects. A goal of this study was to determine the effects of THC and CBD, alone and in combination, on performance in the rodent Psychomotor Vigilance Test (rPVT), a translational paradigm used to quantify sustained attention. Outcome measures in the rPVT include motor speed, premature responding, and lapses in attention. Sprague Dawley rats were trained to perform the rPVT to the acquisition criteria and then received oral doses (mg/kg) of THC (1-17.6), CBD (1-100), and combinations of THC + CBD in sesame oil prior to rPVT sessions, administered in a within-subject randomized design. Blood was collected from rats receiving selected doses of THC alone or THC + CBD for analysis of THC and its metabolites. THC alone produced significant decreases in accuracy and increases in lapses in attention at higher doses (10 mg/kg;

Indexed as

CannabidiolCannabisHallucinogensAnimalsAttentionCannabinoid Receptor AgonistsDronabinolRatsRats, Sprague-DawleyCannabidiolCannabinoid Receptor AgonistsDronabinolHallucinogens

Identifiers

PMID36634015
PMCPMC10938257
OpenAlexW4315752683

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.